Advrs effect of antimalari/drugs acting on bld protzoa, subs

This code signifies a harmful or unintended reaction experienced by a patient due to the therapeutic use of an antimalarial drug or other medication targeting blood protozoa. It specifically indicates that the patient is in the recovery phase of treatment for this adverse effect, following the initial active treatment.

Apply this code when a patient presents for follow-up care, monitoring, or continued management of an adverse drug reaction caused by an antimalarial or similar antiparasitic medication. This includes situations where the initial acute phase of the adverse effect has been addressed, and the patient is now receiving ongoing care for its resolution or long-term sequelae.

• Always sequence this code after the primary diagnosis describing the specific adverse effect (e.g., drug-induced hepatitis, rash).
• Ensure the "D" seventh character is appropriate for a subsequent encounter, indicating ongoing care for the adverse effect.
• Verify the medication involved is an antimalarial or drug acting on other blood protozoa to ensure specificity.